BRIEF-BiondVax – Last Of 12,400 Participants Completes Final Visit In Biondvax’s M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial

BRIEF-BiondVax – Last Of 12,400 Participants Completes Final Visit In Biondvax’s M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial

Advertisement

July 1 (Reuters) – BiondVax Pharmaceuticals Ltd:

* LAST OF 12,400 PARTICIPANTS COMPLETES FINAL VISIT IN BIONDVAX’S M-001 UNIVERSAL FLU VACCINE PIVOTAL PHASE 3 CLINICAL TRIAL

* BIONDVAX PHARMACEUTICALS – EQUIPMENT INSTALLATION, MANUFACTURING PROCESS SCALE-UP IN BIONDVAX’S PILOT FACILITY IN JERUSALEM ARE IN PROGRESS Source text for Eikon: Further company coverage:

Advertisement

Our Correspondent

Related Articles

Lebanon reports that Israeli attacks in the south on Sunday killed at least 21 people.

Lebanon reports that Israeli attacks in the south on Sunday killed at least 21 people.

Following the strike, the head of Iran’s Guards warns Israel of “bitter consequences.”

Following the strike, the head of Iran’s Guards warns Israel of “bitter consequences.”

Iraq complains to the UN over Israel attacking Iran in its airspace.

Iraq complains to the UN over Israel attacking Iran in its airspace.

Russia is making every effort to defuse tensions in the Middle East, according to the Kremlin.

Russia is making every effort to defuse tensions in the Middle East, according to the Kremlin.

Targeting Israeli forces in south Lebanon, according to Hezbollah

Targeting Israeli forces in south Lebanon, according to Hezbollah

Israel’s use of Iraqi airspace during the Iran strike has drawn criticism from the UN.

Israel’s use of Iraqi airspace during the Iran strike has drawn criticism from the UN.